Search research articles
Contact Us
Filters
Showing results (101-110 of 466) with videos related to
Page
of 47
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 19, 2009
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
Federico Pea, Mario Furlanut, Camilla Negri, et al.
The Journal of Antimicrobial Chemotherapy
|
February 3, 2016
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?
Piergiorgio Cojutti, Silvia Duranti, Miriam Isola, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections
Milo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
December 14, 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
Giorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 8, 2026
ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections
Milo Gatti, Riccardo De Paola, Matteo Rinaldi, et al.
Journal of Transplantation
|
July 15, 2010
Disseminate fungal infection after acute pancreatitis in a simultaneous pancreas-kidney recipient
Anna Rossetto, Umberto Baccarani, Dario Lorenzin, et al.
Pharmaceutics
|
February 25, 2023
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Le Infezioni in Medicina
|
January 10, 2013
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases]
Pierluigi Viale, Sara Tedeschi, Fabio Tumietto, et al.
Microorganisms
|
December 23, 2023
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections
Pier Giorgio Cojutti, Simone Giuliano, Renato Pascale, et al.
Page
of 47
Search research articles
Search
Showing results (101-110 of 466) with videos related to
Sort By:
Page
of 47
Antimicrobial Agents and Chemotherapy
|
February 19, 2009
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
Federico Pea, Mario Furlanut, Camilla Negri, et al.
The Journal of Antimicrobial Chemotherapy
|
February 3, 2016
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?
Piergiorgio Cojutti, Silvia Duranti, Miriam Isola, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections
Milo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
December 14, 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
Giorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 8, 2026
ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections
Milo Gatti, Riccardo De Paola, Matteo Rinaldi, et al.
Journal of Transplantation
|
July 15, 2010
Disseminate fungal infection after acute pancreatitis in a simultaneous pancreas-kidney recipient
Anna Rossetto, Umberto Baccarani, Dario Lorenzin, et al.
Pharmaceutics
|
February 25, 2023
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Le Infezioni in Medicina
|
January 10, 2013
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases]
Pierluigi Viale, Sara Tedeschi, Fabio Tumietto, et al.
Microorganisms
|
December 23, 2023
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections
Pier Giorgio Cojutti, Simone Giuliano, Renato Pascale, et al.
Page
of 47